Healius Ltd
ASX:HLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.8), the stock would be worth AU$1.49 (177% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | AU$0.54 |
0%
|
| 3-Year Average | 0.8 | AU$1.49 |
+177%
|
| 5-Year Average | 0.9 | AU$1.73 |
+222%
|
| Industry Average | 1.6 | AU$3.11 |
+479%
|
| Country Average | 4.1 | AU$7.7 |
+1 334%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
AU$490.1m
|
/ |
Jan 2026
AU$1.4B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2026
AU$1.4B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2027
AU$1.5B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2028
AU$1.5B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2029
AU$1.6B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2030
AU$1.7B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2031
AU$1.8B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2032
AU$1.8B
|
= |
|
|
AU$490.1m
|
/ |
Jun 2033
AU$1.9B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
H
|
Healius Ltd
ASX:HLS
|
384.9m AUD | 0.3 | -2.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 0.2 | 56.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 0.3 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0.3 | 12.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 1 | 18 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 1.9 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 11.8 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 0.8 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 4.1 |
| 70th Percentile | 11.8 |
| Max | 1 679 509.2 |
Other Multiples
Healius Ltd
Glance View
Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The firm also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.
